FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4292122063> ?p ?o ?g. }

• W4292122063 abstract "Abstract INTRODUCTION: Lymphatic malformations (LM) are rare congenital anomalies. The traditional treatment is surgical excision, but intralesional sclerosing agent injection is now preferred because of frequent recurrences after surgery, poor cosmetic results, and a high complication rate. We aimed to evaluate the efficacy of sclerosing agent injection used in the treatment of LMs in children. MATERIALS AND METHODS: We retrospectively analyzed the age, gender, admission symptoms, physical examination findings, radiological imaging results, treatment methods, complications, length of hospital stay, and outcomes of children treated for LM between January 2011 and January 2022. The lesion sizes of the patients who underwent sclerosant (Bleomycin) injection under general anesthesia were recorded before and after the treatment, and the difference between them was evaluated statistically. RESULTS: Fifteen patients were retrospectively analyzed. The mean age was 45.2+- 14.1 months (min:3- median:17- max:210). Of these, 10 (66.6%) were male and 5 (33.3%) were female (F/M=1/2). The mean age of male patients was 55 +- 20.1 months (min :3- max:210 months); The mean age of the female patients was 25.8 + - 11.2 (min 3- max: 66 months). Seven patients had a single dose, two had twice and six had three and more. Three patients had LM in different localisations simultaneously. After the sclerosant injection, surgery was performed on 2 patients, and the tissue that became a mass was removed. The average lesion size before the treatment was 55.2+-28.4 mm; after treatment: 23.8+-18.2mm. With the statistical analysis, it was seen that there was a statistically significant difference between the dimensions before and after the treatment (p<0.05) and the sclerosant injection had a great effect on the treatment (R:0.89). CONCLUSION: Intralesional injection of bleomycin is less effective for microcystic or mixed type LMs, but provides effective reduction for a safe surgical procedure. It is an effective treatment for macrocystic lesions." @default.
• W4292122063 created "2022-08-17" @default.
• W4292122063 creator A5012618979 @default.
• W4292122063 creator A5030637672 @default.
• W4292122063 creator A5032747604 @default.
• W4292122063 creator A5036571638 @default.
• W4292122063 creator A5045704166 @default.
• W4292122063 creator A5084867345 @default.
• W4292122063 date "2022-08-17" @default.
• W4292122063 modified "2023-10-17" @default.
• W4292122063 title "Effıcıency And Clınıcal Results Of Bleomısın Injectıon In The Treatment Of Lymphatıc Malformatıons" @default.
• W4292122063 cites W2023760291 @default.
• W4292122063 cites W2034616626 @default.
• W4292122063 cites W2060074319 @default.
• W4292122063 cites W2475502762 @default.
• W4292122063 cites W2807211812 @default.
• W4292122063 cites W3001816714 @default.
• W4292122063 cites W3043590483 @default.
• W4292122063 cites W3091608202 @default.
• W4292122063 cites W3110876411 @default.
• W4292122063 cites W3158910414 @default.
• W4292122063 cites W4213282699 @default.
• W4292122063 doi "https://doi.org/10.21203/rs.3.rs-1964054/v1" @default.
• W4292122063 hasPublicationYear "2022" @default.
• W4292122063 type Work @default.
• W4292122063 citedByCount "0" @default.
• W4292122063 crossrefType "posted-content" @default.
• W4292122063 hasAuthorship W4292122063A5012618979 @default.
• W4292122063 hasAuthorship W4292122063A5030637672 @default.
• W4292122063 hasAuthorship W4292122063A5032747604 @default.
• W4292122063 hasAuthorship W4292122063A5036571638 @default.
• W4292122063 hasAuthorship W4292122063A5045704166 @default.
• W4292122063 hasAuthorship W4292122063A5084867345 @default.
• W4292122063 hasBestOaLocation W42921220631 @default.
• W4292122063 hasConcept C141071460 @default.
• W4292122063 hasConcept C167135981 @default.
• W4292122063 hasConcept C190892606 @default.
• W4292122063 hasConcept C2781156865 @default.
• W4292122063 hasConcept C71924100 @default.
• W4292122063 hasConcept C81182388 @default.
• W4292122063 hasConceptScore W4292122063C141071460 @default.
• W4292122063 hasConceptScore W4292122063C167135981 @default.
• W4292122063 hasConceptScore W4292122063C190892606 @default.
• W4292122063 hasConceptScore W4292122063C2781156865 @default.
• W4292122063 hasConceptScore W4292122063C71924100 @default.
• W4292122063 hasConceptScore W4292122063C81182388 @default.
• W4292122063 hasLocation W42921220631 @default.
• W4292122063 hasOpenAccess W4292122063 @default.
• W4292122063 hasPrimaryLocation W42921220631 @default.
• W4292122063 hasRelatedWork W2076233053 @default.
• W4292122063 hasRelatedWork W2333879843 @default.
• W4292122063 hasRelatedWork W2417961914 @default.
• W4292122063 hasRelatedWork W2419079049 @default.
• W4292122063 hasRelatedWork W2474039552 @default.
• W4292122063 hasRelatedWork W2945124548 @default.
• W4292122063 hasRelatedWork W3018830891 @default.
• W4292122063 hasRelatedWork W4205361111 @default.
• W4292122063 hasRelatedWork W62711790 @default.
• W4292122063 hasRelatedWork W2089188012 @default.
• W4292122063 isParatext "false" @default.
• W4292122063 isRetracted "false" @default.
• W4292122063 workType "article" @default.